市場調查報告書
商品編碼
1087239

人體疫苗的全球市場:產業分析,趨勢,市場規模,預測(∼2028年)

Human Vaccines Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

出版日期: | 出版商: Infinium Global Research (IGR) | 英文 100 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球人體疫苗的市場規模在2022∼2028年的預測期間中預計將以10%的年複合成長率成長。

本報告提供全球人體疫苗市場相關調查分析,提供市場促進因素,阻礙因素,市場機會,宏觀指標分析,產品·疾病類型·各地區市場分析,企業簡介相關資訊。

目錄

第1章 序文

  • 報告的說明
  • 調查方法
  • 研究途徑

第2章 摘要整理

  • 人體疫苗市場概況
  • 人體疫苗市場預測
  • 人體疫苗市場地區的亮點

第3章 全球人體疫苗:市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 人體疫苗市場的COVID-19影響分析
  • 波特的五力分析
  • IGR-成長矩陣分析
    • IGR-成長矩陣分析:各產品
    • IGR-成長矩陣分析:各疾病類型
    • IGR-成長矩陣分析:各地區
  • 人體疫苗市場價值鏈分析

第4章 人體疫苗市場宏觀指標分析

第5章 全球人體疫苗市場:各產品

  • 減毒活病毒疫苗
  • 滅活疫苗
  • 結合型疫苗
  • 合成疫苗
  • 其他

第6章 全球人體疫苗市場:各疾病類型

  • 肺炎
  • 流感
  • 肝炎
  • HPV
  • 其他

第7章 全球人體疫苗市場:各地區(2022∼2028年)

  • 北美
    • 各產品
    • 各疾病類型
    • 各國
  • 歐洲
    • 各產品
    • 各疾病類型
    • 各國
  • 亞太地區
    • 各產品
    • 各疾病類型
    • 各國
  • 其他地區
    • 各產品
    • 各疾病類型
    • 各子地區

第8章 企業簡介和競爭情形

  • 競爭情形
  • 企業簡介
    • GlaxoSmithKline Plc
    • CSL Limited
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.
    • Tadeka Pharmaceutical Company Limited
    • Emergent BioSolutions, Inc.
    • Bavarian Nordic
    • Sanofi Pasteur
    • Serum Institute of India Pvt Ltd
目錄
Product Code: HC0078

The report on the global human vaccines market provides qualitative and quantitative analysis for the period from 2020 to 2028. The report predicts the global human vaccines market to grow with a CAGR of 10% over the forecast period from 2022-2028. The study on human vaccines market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.

The report on human vaccines market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global human vaccines market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global human vaccines market over the period of 2020 to 2028. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • High occurrences of various viral and bacterial diseases
  • Growing health initiatives and awareness campaigns

2) Restraints

  • Stringent regulations for vaccine approval

3) Opportunities

  • Expansion of market players in emerging economies

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global human vaccines market is segmented on the basis of product, and disease type.

The Global Human Vaccines Market by Product

  • Live Attenuated Vaccines
  • Killed Vaccines
  • Conjugate Vaccines
  • Synthetic Vaccines
  • Others

The Global Human Vaccines Market by Disease Type

  • Pneumonia
  • Influenza
  • Hepatitis
  • HPV
  • Others

Company Profiles

The companies covered in the report include

  • GlaxoSmithKline Plc
  • CSL Limited
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Tadeka Pharmaceutical Company Limited
  • Emergent BioSolutions, Inc.
  • Bavarian Nordic
  • Sanofi Pasteur
  • Serum Institute of India Pvt Ltd

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the human vaccines market.

2. Complete coverage of all the segments in the human vaccines market to analyze the trends, developments in the global market and forecast of market size up to 2028.

3. Comprehensive analysis of the companies operating in the global human vaccines market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Human Vaccines Market Highlights
  • 2.2. Human Vaccines Market Projection
  • 2.3. Human Vaccines Market Regional Highlights

3. Global Human Vaccines Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Human Vaccines Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Product
    • 3.5.2. IGR-Growth Matrix Analysis by Disease Type
    • 3.5.3. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Human Vaccines Market

4. Human Vaccines Market Macro Indicator Analysis

5. Global Human Vaccines Market by Product

  • 5.1. Live Attenuated Vaccines
  • 5.2. Killed Vaccines
  • 5.3. Conjugate Vaccines
  • 5.4. Synthetic Vaccines
  • 5.5. Others

6. Global Human Vaccines Market by Disease Type

  • 6.1. Pneumonia
  • 6.2. Influenza
  • 6.3. Hepatitis
  • 6.4. HPV
  • 6.5. Others

7. Global Human Vaccines Market by Region 2022-2028

  • 7.1. North America
    • 7.1.1. North America Human Vaccines Market by Product
    • 7.1.2. North America Human Vaccines Market by Disease Type
    • 7.1.3. North America Human Vaccines Market by Country
  • 7.2. Europe
    • 7.2.1. Europe Human Vaccines Market by Product
    • 7.2.2. Europe Human Vaccines Market by Disease Type
    • 7.2.3. Europe Human Vaccines Market by Country
  • 7.3. Asia-Pacific
    • 7.3.1. Asia-Pacific Human Vaccines Market by Product
    • 7.3.2. Asia-Pacific Human Vaccines Market by Disease Type
    • 7.3.3. Asia-Pacific Human Vaccines Market by Country
  • 7.4. RoW
    • 7.4.1. RoW Human Vaccines Market by Product
    • 7.4.2. RoW Human Vaccines Market by Disease Type
    • 7.4.3. RoW Human Vaccines Market by Sub-region

8. Company Profiles and Competitive Landscape

  • 8.1. Competitive Landscape in the Global Human Vaccines Market
  • 8.2. Companies Profiles
    • 8.2.1. GlaxoSmithKline Plc
    • 8.2.2. CSL Limited
    • 8.2.3. Merck & Co., Inc.
    • 8.2.4. Novartis AG
    • 8.2.5. Pfizer, Inc.
    • 8.2.6. Tadeka Pharmaceutical Company Limited
    • 8.2.7. Emergent BioSolutions, Inc.
    • 8.2.8. Bavarian Nordic
    • 8.2.9. Sanofi Pasteur
    • 8.2.10. Serum Institute of India Pvt Ltd